India-China border tiff may derail $1.3 bn Fosun-Gland Pharma deal

By Ranjani Raghavan

  • 21 Jul 2017
Premium
Credit: Reuters

The biggest ever Chinese acquisition on Indian soil may flounder as a border standoff between the two countries has cast a shadow over Shanghai Fosun Pharmaceutical Ltd’s proposed acquisition of Hyderabad-based Gland Pharma Ltd, three people familiar with the matter told VCCircle.Fosun had, in July last year, struck a deal ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.